Antimicrobial efficacy of novel XF compounds for the prevention, control and eradication of clinically and industrially relevant pathogens and biofilms

Application/Funding: Costed

Applicants

Organisations

Details

Funding organisationDestiny Pharma Plc
Application date17/07/18
Total application£39,714.00
Awarded date26/07/18
Total award£39,714.00

View graph of relations

Employable Graduates; Exploitable Research

Copy the text from this field...